Decreased levels of the cell-cycle inhibitor p27(Kip1) protein: Prognostic implications in primary breast cancer

Nature Medicine

Volumn 3, Issue 2, 1997, Pages 227-230

  Catzavelos, Charles ^a   Bhattacharya, Nandita ^a   Ung, Yee C ^b   Wilson, James A ^a   Roncari, Luba ^a   Sandhu, Charanjit ^a   Shaw, Patricia ^a   Yeger, Herman ^c   Morava Protzner, Isabella ^a   Kapusta, Linda ^a   Franssen, Edmée ^b   Pritchard, Kathleen I ^b   Slingerland, Joyce M ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYTOKINE; PROTEIN P27; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BREAST CANCER; CELL CYCLE; IMMUNOHISTOCHEMISTRY; MITOSIS INHIBITION; PRIORITY JOURNAL; PROGNOSIS; REGULATORY MECHANISM;

BREAST NEOPLASMS; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; FEMALE; GENES, CDC; HUMANS; IMMUNOHISTOCHEMISTRY; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 16944363001     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0297-227     Document Type: Article

References (20)

1. Harris, J.R. & Henderson, I.C. Staging and prognostic factors. in Breast Diseases, 2nd edn. (ed. Harris, J.R.) 327-346 (Lippincott, Philadelphia, 1987).
2. Morgan, D.O. Principles of Cdk regulation. Nature 374, 131-134 (1995).
3. 1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163 (1995).
4. Reed, S.I. et al. G1 control in mammalian cells. J. Cell Sci. 18 (Suppl.), 69-73 (1994).
5. Koff, A. et al. Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-β. Science 260, 536-539 (1993).
6. kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22 (1994).
7. Slingerland, J.M. et al. A novel inhibitor of cyclin/Cdk activity detected in TGF-β arrested epithelial cells. Mol. Cell Biol. 14, 3683-3694 (1994).
8. Hunter, T. & Pines, P. Cyclins and cancer II: Cyclin D and cdk inhibitors come of age. Cell 79, 573-582 (1994).
9. kip1 in primary breast carcinomas. Hum. Genet. 97, 91-94 (1996).
10. Stampfer, M.R. & Bartley, J.C. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc. Natl. Acad. Sci. USA 82, 2392-2398 (1985).
11. kip1 accumulation during the cell cycle. Science 271, 1861-1864 (1996).
12. Pagano, M. et al. Role of ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682-685 (1995).
13. Fang, F. et al. Dependence of cyclin E-Cdk2 kinase activity on cell anchorage. Science 271, 499-502 (1996).
14. Loda, M. et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med. 3, 230-233 (1996).
15. kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3, 222-224 (1996).
16. Zhu, X. et al. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol. 133, 391-403 (1996).
17. kip1 on adhesion-dependent resistance of tumor cells to anticancer agents. Nature Med. 2, 1204-1210 (1996).
18. SAS/SAT User's Guide, Version 6, 4th edn., Vol. 2, 1027-1069 (The SAS Institute, Inc., Cary, NC, 1989).
19. Toyoshima, H. & Hunter, T. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78, 67-74 (1994).
20. Wang, D., Yeger, H. & Cutz, E. Expression of gastrin-releasing peptide receptor gene in developing lung. Am. J. Respir. Cell Mol. Biol. 14, 409-416 (1996).